This article examines the critical workforce capacity gaps threatening the progress of cancer research and drug development.
This article provides a comprehensive analysis of the profound inequities shaping the global cancer research funding landscape.
This article addresses the critical challenge of time as a major barrier in cancer clinical trials, a pressing issue for researchers, scientists, and drug development professionals.
This article examines the critical limitations in cancer research infrastructure within Low- and Middle-Income Countries (LMICs), where the global cancer burden is rising most sharply.
This article provides a comprehensive analysis of the current funding landscape for investigator-initiated cancer trials (IITs), examining the profound impact of recent federal budget cuts, disparities in research funding, and...
This article provides a comprehensive analysis for researchers, scientists, and drug development professionals on the systemic barriers impeding cancer clinical trial capacity in low- and middle-income countries (LMICs).
This comprehensive review synthesizes current advancements in pan-cancer analyses of the tumor immune microenvironment (TIME).
This article provides a comprehensive overview of the validation strategies for computational models that predict drug response from single-cell RNA sequencing (scRNA-seq) data.
This article provides a comprehensive guide for researchers and drug development professionals on integrating single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq data.
This article provides a comprehensive guide for researchers and drug development professionals on validating single-cell RNA sequencing (scRNA-seq) clusters using spatial transcriptomics (ST).